Lansoprazole-contained freeze-dried powder injection
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CHANGZHOU NO 4 PHARMA FACTORY
- Publication Date
- 2010-11-03
Abstract
Description
technical field
[0001] The invention provides a freeze-dried powder injection, especially a freeze-dried powder injection containing lansoprazole. Background technique
[0002] Lansoprazole is a substituted benzimidazole compound anti-ulcer drug, which belongs to the proton pump inhibitor. It can continuously inhibit the activity of gastric acid and pepsin by inhibiting the proton pump of gastric mucosa parietal cells, that is, inhibiting the activity of H+, K+-ATPase. secretion. According to the research results of peptic ulcer in recent years, lansoprazole is obviously better than omeprazole, which is widely used in clinical practice, in the treatment of duodenal ulcer (DU). Lansoprazole has reliable acid-suppressing effects and a large safety factor, and is a promising new generation of proton pump inhibitors. Only oral preparations are listed on the domestic market at present. Injections have the advantages of quick onset and are not affected by the gastrointestinal e...